The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
Open accessAbstract
PURPOSE: The aim of this "Year in Review" article is to summarize and discuss the implications of biochemical marker related articles published between the Osteoarthritis Research Society International (OARSI) 2015 Congress in Seattle and the OARSI 2016 Congress in Amsterdam. METHODS: The PubMed/MEDLINE bibliographic database was searched using the combined keywords: 'biomarker' and 'osteoarthritis'. The PubMed/MEDLINE literature search was conducted using the Advanced Search Builder function (http://www.ncbi.nlm.nih.gov/pubmed/advanced). RESULTS: Over two hundred new biomarker-related papers were published during the literature search period. Some papers identified new biomarkers whereas others explored the biological properties and clinical utility of existing markers. There were specific references to several adipocytokines including leptin and adiponectin. ADAM Metallopeptidase with Thrombospondin Type 1 motif 4 (ADAMTS-4) and aggrecan ARGS neo-epitope fragment (ARGS) in synovial fluid (SF) and plasma chemokine (CeC motif) ligand 3 (CCL3) were reported as potential new knee biomarkers. New and refined proteomic technologies and novel assays including a fluoro-microbead guiding chip (FMGC) for measuring C-telopeptide of type II collagen (CTX-II) in serum and urine and a novel magnetic nanoparticle-based technology (termed magnetic capture) for collecting and concentrating CTX-II, were described this past year. CONCLUSION: There has been steady progress in osteoarthritis (OA) biomarker research in 2016. Several novel biomarkers were identified and new technologies have been developed for measuring existing biomarkers. However, there has been no "quantum leap" this past year and identification of novel early OA biomarkers remains challenging. During the past year, OARSI published a set of recommendations for the use of soluble biomarkers in clinical trials, which is a major step forward in the clinical use of OA biomarkers and bodes well for future OA biomarker development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
The epidemiology and impact of pain in osteoarthritis
Neogi, T. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.03.018 · Cited by 1,730
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
Sellam, J., & Berenbaum, F. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.159 · Cited by 1,500
The role of synovitis in osteoarthritis pathogenesis
Scanzello, C. R., & Goldring, S. R. (2012) · Bone · doi:10.1016/j.bone.2012.02.012 · Cited by 1,302
Obesity and Knee Osteoarthritis: The Framingham Study
Felson, D. T., Anderson, J. J., Naimark, A., Walker, A. M., & Meenan, R. F. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-1-18 · Cited by 1,080
Nuesch, E., Dieppe, P., Reichenbach, S., Williams, S., Iff, S., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.d1165 · Cited by 730
Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons - a scoping review
Bliddal, H., Leeds, A. R., & Christensen, R. (2014) · Obesity Reviews · doi:10.1111/obr.12173 · Cited by 380
Value of biomarkers in osteoarthritis: current status and perspectives
Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203726 · Cited by 328
Metabolic stress-induced joint inflammation and osteoarthritis
Courties, A., Gualillo, O., Berenbaum, F., & Sellam, J. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.05.016 · Cited by 249
Biological markers in osteoarthritis
Rousseau, J.-C., & Delmas, P. D. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0508 · Cited by 237
Attur, M., Krasnokutsky, S., Statnikov, A., Samuels, J., Li, Z., Friese, O., Hellio Le Graverand‐Gastineau, M., Rybak, L., Kraus, V. B., Jordan, J. M., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39279 · Cited by 120
Martel-Pelletier, J., Raynauld, J.-P., Dorais, M., Abram, F., & Pelletier, J.-P. (2016) · Rheumatology · doi:10.1093/rheumatology/kev408 · Cited by 68
Cited by
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways
Liu, L., Guo, H., Song, A., Huang, J., Zhang, Y., Jin, S., Li, S., Zhang, L., Yang, C., & Yang, P. (2020) · BMC Immunology · doi:10.1186/s12865-020-00355-y · Cited by 289
Targeting the gut microbiome to treat the osteoarthritis of obesity
Schott, E. M., Farnsworth, C. W., Grier, A., Lillis, J. A., Soniwala, S., Dadourian, G. H., Bell, R. D., Doolittle, M. L., Villani, D. A., Awad, H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.95997 · Cited by 268
Metadata
- Authors
- Mobasheri, A., Bay-Jensen, A.-C., van Spil, W. E., Larkin, J., & Levesque, M. C.
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 25
- Issue
- 2
- Pages
- 199-208
- ISSN
- 1063-4584 (ISSN-L)
- OpenAlex
- W2575028522
- Cited by
- 160
- References
- 12
- FWCI
- 17.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.